TrialFrontiers in immunology2022

A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis.

Li Di et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.